Repare Therapeutics Stock News

Repare Therapeutics Inc (RPTX) shares closed this week 21.0% lower than it did at the end of last week. The stock is currently down 21.0% year-to-date, down 60.9% over the past 12 months, and down 45.9% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%. Trading Activity Shares traded as high as $22.20 and as low as $16.51 this week.Shares closed 63.8% below its 52-week high and 0.9% above its 52-week low.Trading volume this week was 30.6% higher than the 10-day average and 68.7% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.3. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price lags the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price lags the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis The company share price lags the performance of its peers in the Health Care industry sector this week, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 7960.2% The company's stock price performance over the past 12 months lags the peer average by 720.6% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Repare Therapeutics Inc (RPTX) shares closed today 11.6% lower than it did at the end of yesterday. The stock is currently down 21.0% year-to-date, down 60.9% over the past 12 months, and down 45.9% over the past five years. Today, the Dow Jones Industrial Average fell 0.0%, and the S&P 500 fell 0.4%. Trading Activity Shares traded as high as $22.20 and as low as $16.51 this week.Shares closed 63.8% below its 52-week high and 0.9% above its 52-week low.Trading volume this week was 30.6% higher than the 10-day average and 68.7% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.3. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price lags the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price lags the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis The company share price lags the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 7960.2% The company's stock price performance over the past 12 months lags the peer average by 720.6% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Repare Therapeutics Inc (RPTX) shares closed today at 0.9% above its 52 week low of $16.51, giving the company a market cap of $695M. The stock is currently down 21.0% year-to-date, down 60.9% over the past 12 months, and down 45.9% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%. Trading Activity Trading volume this week was 70.7% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.3. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 7960.2% The company's stock price performance over the past 12 months lags the peer average by 720.6% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Repare Therapeutics Inc (RPTX) shares closed today 11.6% lower than it did at the end of yesterday. The stock is currently down 21.0% year-to-date, down 62.5% over the past 12 months, and down 45.9% over the past five years. Today, the Dow Jones Industrial Average fell 0.0%, and the S&P 500 fell 0.4%. Trading Activity Shares traded as high as $22.20 and as low as $16.51 this week.Shares closed 63.8% below its 52-week high and 0.9% above its 52-week low.Trading volume this week was 51.5% higher than the 10-day average and 70.7% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.3. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price lags the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price lags the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis The company share price lags the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 7960.2% The company's stock price performance over the past 12 months lags the peer average by 614.7% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Repare Therapeutics Inc (RPTX) shares closed today at 0.9% above its 52 week low of $16.51, giving the company a market cap of $695M. The stock is currently down 21.0% year-to-date, down 62.5% over the past 12 months, and down 45.9% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%. Trading Activity Trading volume this week was 70.7% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.3. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 7960.2% The company's stock price performance over the past 12 months lags the peer average by 614.7% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Repare Therapeutics (RPTX) provides key milestones anticipated in 2022.Initiation of a monotherapy Phase 2 TRESR trial of RP-3500, for the treatment of solid tumors with…

Wall Street brokerages expect that Repare Therapeutics Inc. (NASDAQ:RPTX) will report sales of $2.62 million for the current fiscal quarter, according to Zacks Investment Research. Three analysts have made estimates for Repare Therapeutics earnings, with the lowest sales estimate coming in at $200,000.00 and the highest estimate coming in at $7.40 million. Repare Therapeutics posted []

CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (Repare or the Company) (Nasdaq: RPTX), a leading clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics, today announced that each of its: President and Chief Executive Officer, Lloyd Segal; Executive Vice President and Chief Financial Officer, Steve Forte; Executive Vice-President and Chief Scientific Officer, Michael Zind

Shares of Repare Therapeutics Inc. (NASDAQ:RPTX) gapped down prior to trading on Friday . The stock had previously closed at $21.19, but opened at $20.72. Repare Therapeutics shares last traded at $20.72, with a volume of 2 shares changing hands. Several brokerages have commented on RPTX. Morgan Stanley raised their price target on shares of []

Shares of Repare Therapeutics Inc. (NASDAQ:RPTX) have been given an average rating of Buy by the eight brokerages that are currently covering the firm, MarketBeat reports. One research analyst has rated the stock with a sell recommendation and seven have issued a buy recommendation on the company. The average twelve-month price objective among analysts that []

Wall Street analysts forecast that Repare Therapeutics Inc. (NASDAQ:RPTX) will announce sales of $2.62 million for the current quarter, Zacks reports. Three analysts have issued estimates for Repare Therapeutics earnings, with the highest sales estimate coming in at $7.40 million and the lowest estimate coming in at $200,000.00. Repare Therapeutics reported sales of $140,000.00 in []

Shares of Repare Therapeutics Inc. (NASDAQ:RPTX) traded up 12.6% during mid-day trading on Tuesday . The company traded as high as $22.96 and last traded at $22.82. 1,223 shares were traded during mid-day trading, a decline of 99% from the average session volume of 170,537 shares. The stock had previously closed at $20.27. A number []

Equities analysts expect Repare Therapeutics Inc. (NASDAQ:RPTX) to post earnings of ($0.74) per share for the current fiscal quarter, Zacks Investment Research reports. Three analysts have provided estimates for Repare Therapeutics’ earnings, with the highest EPS estimate coming in at ($0.61) and the lowest estimate coming in at ($0.84). Repare Therapeutics posted earnings per share […]

Renaissance Technologies LLC bought a new stake in Repare Therapeutics Inc. (NASDAQ:RPTX) in the second quarter, Holdings Channel reports. The institutional investor bought 20,400 shares of the companys stock, valued at approximately $636,000. Several other large investors have also made changes to their positions in the company. FMR LLC raised its holdings in shares of []

Repare Therapeutics Inc. (NASDAQ:RPTX) EVP Michael Zinda sold 20,000 shares of Repare Therapeutics stock in a transaction on Monday, November 15th. The shares were sold at an average price of $27.33, for a total value of $546,600.00. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. []